News Alexion signs R&D deals with two Nordic biotechs Alexion has signed a deal with two Nordic biotechs to bolster its pipeline of potential rare disease drugs.
News AZ boosts vaccine capabilities with Omniose buy AstraZeneca has bought a US biotech developing polysaccharide conjugate vaccines for bacterial infections, Omniose, after a three-year partnership.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
